Seelos Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 12658000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-03-31) |
| Status | current |
| Entity | Seelos Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:53:13.881238+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/76ec23a3-7bc1-4f52-8901-bf6b3844a2d1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001136261-21-000064 · Open the official SEC filing →Retrieved: 2026-08-19T09:53:13.881238+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001017491/cash-and-equivalents/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/76ec23a3-7bc1-4f52-8901-bf6b3844a2d1
History
- supersedes {"amount": 12688000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001136261-20-000114)